[HTML][HTML] Role of p53 in breast cancer progression: An insight into p53 targeted therapy

C Marvalim, A Datta, SC Lee - Theranostics, 2023 - ncbi.nlm.nih.gov
The transcription factor p53 is an important regulator of a multitude of cellular processes. In
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …

The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors

H Hou, D Sun, X Zhang - Cancer cell international, 2019 - Springer
The MDM2 protein encoded by the mouse double minute 2 (MDM2) gene is the primary
negative regulatory factor of the p53 protein. MDM2 can ligate the p53 protein via its E3 …

p53 as a target for the treatment of cancer

MJ Duffy, NC Synnott, PM McGowan, J Crown… - Cancer treatment …, 2014 - Elsevier
Abstract TP53 (p53) is the most frequently mutated gene in cancer, being altered in
approximately 50% of human malignancies. In most, if not all, cancers lacking mutation, wild …

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

X Wang, F Wang, M Zhong, Y Yarden, L Fu - Molecular cancer, 2020 - Springer
Immune checkpoint inhibitors (ICIs), such as PD-1/PD-L1 antibodies (Abs) and anti-cytotoxic
T lymphocyte antigen 4 (CTLA-4) Abs, are effective for patients with various cancers …

[HTML][HTML] PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective

X Han, W Wei, Y Sun - Acta materia medica, 2022 - ncbi.nlm.nih.gov
Abstract Mouse double minute 2 (MDM2) is an E3 ubiquitin ligase which effectively
degrades tumor suppressor p53. In the past two decades, many MDM2 inhibitors that disrupt …

Killing by degradation: regulation of apoptosis by the ubiquitin-proteasome-system

R Abbas, S Larisch - Cells, 2021 - mdpi.com
Apoptosis is a cell suicide process that is essential for development, tissue homeostasis and
human health. Impaired apoptosis is associated with a variety of human diseases, including …

Role of dietary antioxidants in p53‐mediated cancer chemoprevention and tumor suppression

JPJ Merlin, HPV Rupasinghe… - … Medicine and Cellular …, 2021 - Wiley Online Library
Cancer arises through a complex interplay between genetic, behavioral, metabolic, and
environmental factors that combined trigger cellular changes that over time promote …

[HTML][HTML] Natural products targeting the p53-MDM2 pathway and mutant p53: recent advances and implications in cancer medicine

JJ Qin, X Li, C Hunt, W Wang, H Wang, R Zhang - Genes & diseases, 2018 - Elsevier
The p53 tumor suppressor plays a major role in controlling the initiation and development of
cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 …

Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?

P Dhakal, M Bates, MH Tomasson, G Sutamtewagul… - Blood reviews, 2023 - Elsevier
Venetoclax is a highly selective B-cell lymphoma-2 (BCL-2) inhibitor, which, combined with
a DNA hypomethylating agent or low dose cytarabine, results in high rates of initial …

The role and function of microRNA in the pathogenesis of multiple myeloma

H Handa, Y Murakami, R Ishihara, K Kimura-Masuda… - Cancers, 2019 - mdpi.com
Recently, attention has been drawn to the role of non-coding regions of the genome in
cancer pathogenesis. MicroRNAs (miRNAs) are small non-coding RNAs with 19–25 bases …